Bringing the fundamentals into focus…
Back to Theravance Biopharma Inc
How Theravance Biopharma Inc stacks up
TBPH · against 482 other Healthcare companies of similar size
Profitability
49/ 100
Above the middle of the pack.
Ranked #224 of 483 · scores higher than 53% of peers
Bars: peers in each 10-point band of the profitability score61 peers with a profitability score of 40–49, including TBPH · Click a bar to see the companies
Why profitability scores 49?
Weighted metrics compared with all Healthcare companies.A mix: stronger return on assets, but weaker return on invested capital and operating margin than most Healthcare peers.
- a lower return on invested capital: weaker than 71% of peers. Return on invested capital: -4.7% vs peer median 4.7%
- a thinner operating margin: weaker than 70% of peers. Operating margin: -4.0% vs peer median 7.1%
- a higher return on assets: stronger than 92% of peers. Return on assets: 11.5% vs peer median 1.7%
Metric by metric
Position: dot = TBPH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TBPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 457 reported | -4.7% | 3.7% | 29% | 33% | |
| Operating marginHigher is better · 452 reported | -4.0% | 5.7% | 30% | 33% | |
| Return on assetsHigher is better · 475 reported | 11.5% | 1.4% | 93% | 33% | |
| Return on equityHigher is better · 453 reported | 20.9% | 2.4% | 93% | Context only | |
| Gross marginHigher is better · 502 reported | 75.1% | 45.5% | 83% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around TBPH| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 2 | 578M USD | 99 | 73 | |
| 224 | 3.8B CNY (≈$528M) | 49 | 59 | |
| 224 | 6.2B CNY (≈$861M) | 49 | 35 | |
| 224 | 3.7B CNY (≈$513M) | 49 | 37 | |
| 224 | 474M USD | 49 | 46 | |
| 224 | 884M USD | 49 | 75 | |
| 229 | 4.6B CNY (≈$646M) | 48 | 53 | |
| 229 | 3.7B CNY (≈$520M) | 48 | 42 | |
| 229 | 7.1B CNY (≈$989M) | 48 | 38 | |
| 229 | 9.3B CNY (≈$1.3B) | 48 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score